Skip to product information
1 of 1

TPO (332aa) Protein, Human

TPO (332aa) Protein, Human

Catalog Number: UA040350 Reactivity: Human Conjugation: Unconjugated Brand: UA BIOSCIENCE
Price:
Regular price $160 USD
Regular price Sale price $160 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Human
Synonyms Thrombopoietin; C-mpl ligand (ML); Megakaryocyte colony-stimulating factor; Megakaryocyte growth and development factor (MGDF); Myeloproliferative leukemia virus oncogene ligand;
Accession P40225
Amino Acid Sequence

Ser22-Gly353 with C terminal His Tag

Expression System HEK293
Molecular Weight

80-90 kDa (Reducing)

Purity >95% by SDS-PAGE.
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag His Tag
Physical Appearance Lyophilized Powder
Storage Buffer

PBS, pH7.4

Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage

· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.

· 3 months, -20 to -80℃ under sterile conditions after reconstitution.

· 1 week, 2 to 8℃ under sterile conditions after reconstitution.

· Please avoid repeated freeze-thaw cycles.

Reference

Nature. 1994 Jun 16;369(6481):533-8.
Blood.2002 Nov 15;100(10):3457-69.

Background

Thrombopoietin (TPO) is a glycoprotein hormone that plays a critical role in the regulation of platelet production and megakaryopoiesis, the process by which megakaryocytes give rise to platelets. TPO acts on hematopoietic stem cells and progenitor cells in the bone marrow, stimulating their differentiation into megakaryocytes and promoting platelet formation. TPO exerts its effects by binding to the c-Mpl receptor on the surface of hematopoietic cells, leading to the activation of signaling pathways that regulate cell proliferation, survival, and differentiation. Dysregulation of TPO signaling has been implicated in various hematological disorders, such as thrombocytopenia and myeloproliferative neoplasms.

Picture

Bioactivity

Measured in a cell proliferation assay using M-07e human megakaryocytic leukemic cells. The EC50 for this effect is less than 1ng/ml.

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)